Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Feilin Cao"'
Autor:
Ling Xu, Yixin Zhou, Lijie Chen, Abdul Saad Bissessur, Jida Chen, Misha Mao, Siwei Ju, Lini Chen, Cong Chen, Zhaoqin Li, Xun Zhang, Fei Chen, Feilin Cao, Linbo Wang, Qinchuan Wang
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Aberrant methylation has been regarded as a hallmark of cancer. 5-hydroxymethylcytosine (5hmC) is recently identified as the ten-eleven translocase (ten-eleven translocase)-mediated oxidized form of 5-methylcytosine, which plays a substantial role in
Externí odkaz:
https://doaj.org/article/78a7e34caa6b4e8cbb367bff4a8c8c37
Autor:
Xingqiang Yan, Fanshuang Zhu, Qiupeng Wang, Lijie Chen, Yixing Zhou, Zenggui Wu, Linhang Mei, Zhaosheng Ma, Binbin Cui, Feilin Cao
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Low-grade adenosquamous carcinoma (LGASC) is a rare invasive tumor that occurs in breast parenchyma. It has previously only been reported in females. Herein, we describe the case of a 52-year-old male who presented with a palpable mass in his right a
Externí odkaz:
https://doaj.org/article/f495e313c7e84c27ad27517cfbb3d3f5
Publikováno v:
Genomics Data, Vol 6, Iss C, Pp 214-216 (2015)
Long non-coding RNAs (lncRNAs) are subclass of noncoding RNAs that have been recently shown to play critical roles in cancer biology. However, little is known about their mechanistic role in breast cancer pathogenesis, especially in triple-negative b
Externí odkaz:
https://doaj.org/article/13d74eda1e0a4b158bf8949a21e4eb8c
Autor:
Xingqiang Yan, Ruichao Zeng, Zhaosheng Ma, Chengze Chen, Endong Chen, Xiaohua Zhang, Feilin Cao
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129304 (2015)
The sentinel lymph node (SLN) is defined as the first draining node from the primary lesion, and it has proven to be a good indicator of the metastatic status of regional lymph nodes in solid tumors. The aim of this study was to evaluate the clinical
Externí odkaz:
https://doaj.org/article/7308529268bf445d83be5ad14d30379e
Autor:
Ketao Jin, Guangliang Li, Binbin Cui, Jing Zhang, Huanrong Lan, Na Han, Bojian Xie, Feilin Cao, Kuifeng He, Haohao Wang, Zhenzhen Xu, Lisong Teng, Tieming Zhu
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e28384 (2011)
The lack of appropriate tumor models of primary tumors and corresponding metastases that can reliably predict for response to anticancer agents remains a major deficiency in the clinical practice of cancer therapy. It was the aim of our study to esta
Externí odkaz:
https://doaj.org/article/4afd9dc9425a4cd28899d4fb2af92c7c
Autor:
Feilin Cao, Zhaosheng Ma, Guinv Hu, Xiaotao Zhu, Shuguang Li, Shuzheng Chen, Binglie Chen, Zhanwen Li, Weizhu Wu, Xiaochun Ji, Jingde Shu, Deyou Tao, Xiaoqing Hu, Min Zheng, Ouchen Wang, Qingjing Feng, Jing Hao, Xujun Li
Publikováno v:
Cancer Research. 83:OT2-14
Objective: Trastuzumab-based adjuvant therapy was demonstrated to improve the prognosis of early human epidermal growth factor receptor 2 (HER-2) positive breast cancer, while about 10% of patients showed primary resistance. ExteNET study showed that
Publikováno v:
Clinical Breast Cancer.
Autor:
Li-jie Chen, Fan-shuang Zhu, Wang-jin Xu, Hong-yan Fang, Lin-yi Wang, Zhao-sheng Ma, Feilin Cao
Background: OCRL (Oculocerebrorenal syndrome of Lowe Protein) was originally well-known as the Lowe’s protein. However, the expression, significance and regulation mechanisms of OCRL in any cancers were not clear. Methods: The bioinformation of bre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::520074e2fb81636d68fb642b7757adee
https://doi.org/10.21203/rs.3.rs-2032108/v1
https://doi.org/10.21203/rs.3.rs-2032108/v1
Autor:
Weimin Zhu, Xuefei Zhao, Jianxin Cui, Feilin Cao, Bin Bai, Xia Xia, Wenquan Liang, Juan Wang, Xiao-Tian Ni, Nairen Zheng, Kecheng Zhang, Xin Wei, Xiaosong Wu, Mingwei Liu, Cheng Zhang, Gang Ji, Dongdong Zhan, Jun Qin, Lin Shen, Qingchuan Zhao, Yi Wang, Jinwen Shi, Wang Hongwei, Jipeng Li, Tieliu Shi, Yongzhan Nie, Wenwen Huang, Yongsheng Meng, Li Yazhuo, Zhihao Lu, Lin Chen, Shiqi Wang, Jiafu Ji
Publikováno v:
Science China Life Sciences. 64:1199-1211
While precision medicine driven by genome sequencing has revolutionized cancer care, such as lung cancer, its impact on gastric cancer (GC) has been minimal. GC patients are routinely treated with chemotherapy, but only a fraction of them receive the
Autor:
Wenwen, Huang, Dongdong, Zhan, Yazhuo, Li, Nairen, Zheng, Xin, Wei, Bin, Bai, Kecheng, Zhang, Mingwei, Liu, Xuefei, Zhao, Xiaotian, Ni, Xia, Xia, Jinwen, Shi, Cheng, Zhang, Zhihao, Lu, Jiafu, Ji, Juan, Wang, Shiqi, Wang, Gang, Ji, Jipeng, Li, Yongzhan, Nie, Wenquan, Liang, Xiaosong, Wu, Jianxin, Cui, Yongsheng, Meng, Feilin, Cao, Tieliu, Shi, Weimin, Zhu, Yi, Wang, Lin, Chen, Qingchuan, Zhao, Hongwei, Wang, Lin, Shen, Jun, Qin
Publikováno v:
Science China. Life sciences. 64(8)
While precision medicine driven by genome sequencing has revolutionized cancer care, such as lung cancer, its impact on gastric cancer (GC) has been minimal. GC patients are routinely treated with chemotherapy, but only a fraction of them receive the